zilongwang/ReadingBank huggingface dataset:
Do you have: Request forms which demonstrate that clinical need is included? Appendix 9 Patient records demonstrate that the clinical need is recorded in the patient notes? Appendix 9 Do you have records showing that the elements of this standard have been reviewed against current procedures, and that any identified issues have been actioned? Standard 1.1 Appendix 4 Standard 2.2 Requirements to achieve accreditation against Standard 2.2 NA Related Standards Related appendices Action required Do you have a documented policy for obtaining patient consent prior to a diagnostic imaging procedure being provided at your practice? Standard 1.1 Appendices 2, 3 Does your policy include information about which procedures provided by your practice are invasive or represent a high risk? Appendices 2, 3 Do you have records showing that:
Where contrast is used, documented protocols for use and administration. Appendix 2 a process for capturing information on medication management incidents, and initiating quality improvement activities as a result of these events? Appendix 4 Do you have a protocol which documents the appropriate use and administration of contrast? Standard 3.1 Appendix 2 Do you have records showing that the patient’s medication use, and/or history regarding previous reactions to medications? Standard 2.2 Appendices 9, 10 Can your practice provide records of adverse medication events showing that they have been appropriately documented and investigated? Appendices 4, 9 Do you have records showing that the elements of this standard have been reviewed against current procedures, and that any identified issues have been actioned? Standard 1.1 Appendix 4 Standard 3.1 Requirements to achieve accreditation against Standard 3.1 NA Related Standards Related appendices Action required
Do you have records which show that your practice annually compares your facility or practice reference level (FRL or PRL) to the published DRL? Standard 1.1 Appendices 2, 3, 4 If DRLS are exceeded, do you have records showing that the settings on your equipment are reviewed to determine whether radiation protection has been optimized? Standard 1.1 Appendices 2, 3, 4 Standard 4.1 Requirements to achieve accreditation against Standard 4.1 NA Related Standards Related appendices Action required Does your Practice have a documented policy for the provision of reports to requesting practitioners and patients? Standard 1.1 Appendices 2, 3 Do your imaging reports for each modality contain the information as described in your policy? Appendix 9 Do you have records which describe actions taken in response to feedback from requesting practitioners about the content or provision of reports? Standard 1.1 Appendix 4
APPENDIX I EBMT-CTIWP Retrospective Study: Consensus guidelines of the European Group for Blood and Marrow Transplantation for monitoring post-transplant immune reconstitution Team details: CIC n° Hospital Unit Name Email Telephone Fax Principal investigator Data manager Current practice in your centre for the monitoring of post-transplant immune reconstitution: ASSAYS Clinical vs investigational use vs not available Are you planning to implement this test (in house or with other centers) in the next year?Are you planning to implement this test (in house or in coll. With other centers) in the next year? Comments HSCT from sibling donor: Y vs N HSCT from volunteer unrelated donor: Y vs N HSCT from donor: Y vs N HSCT from unit: Y vs N Quantitative tests Hematology: CBC with differential (neutrophils, lymphocytes) □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Clinical laboratory: Immunoglobulins □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Flow-cytometry: Lymphocyte subsets (T, B and NK absolute counts) □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Flow-cytometry: T-cell subsets □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Flow-cytometry: B-cell subsets □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Flow-cytometry: NK-cell subsets □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Molecular tests: TRECs and KRECs □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Engraftment monitoring Molecular tests: STR, qPCR, Fish, □ Clinical □ Investigational □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No
OthersMolecular tests: STR, qPCR, Fish, Other □ Not available Functional assays Proliferative responses: T polyclonal antigens, CMV, EBV, others □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Antibodies: B cells, response to vaccines □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Elispot: T cells polyclonal antigens, CMV, EBV, others □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Flow cytometry: intracellular cytokines □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Tetramers □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No Immune diversity Molecular tests Spectratyping: TCR and BCR □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No NGS: TCR sequencing BCR sequencing □ Clinical □ Investigational □ Not available □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No □ Yes □ No
2 Julianne Schultz, Reviving the Fourth Estate. Democracy, Accountability and the Media (Cambridge University Press, 1998) 36. 3 Allan Brown, Commercial Media in Australia: economics, ownership, technology and regulation, (University of Queensland Press, 1986) 54-54. 4 R B Walker, The Newspaper Press in New South Wales 1803-1920, (Sydney University Press, 1976) 55. 5 Henry Mayer, The Press In Australia (Lansdowne Press, 1964) 18.
12 Henry Mayer, The Press In Australia (Lansdowne Press, 1964) 56. 13 Ibid 63. 14 Allan Brown, Commercial Media in Australia: economics, ownership, technology and regulation, (University of Queensland Press, 1986) 33. 15 Australian Broadcasting Corporation Annual Report 2015/16 (2016) 164 16 Special Broadcasting Service SBS 2015/16 Annual Report, 76. http://media.sbs.com.au/aboutus/SBS_Annual_Report_2016.pdf. 17 http://www.abc.net.au/news/2014-11-19/abc-funding-cuts-announced-by-malcolm-turnbull/5902774
revenue. The amount is capped at two million baht (approximately $A61 million), but can be adjusted by the Minister of Finance every three years. Alternatively, national broadcasters can be funded with direct grants from government. This approach is used in Australia and Canada. A common feature of national broadcasting funding models is multi-year funding agreements. As articulated in the Council of Europe Guidelines on the guarantee of public service broadcasting: Payment of the contribution or licence fee s should be made in a way which guarantees the continuity of the activities of the public service broadcasting organisation and which allows it to engage in long-term planning. Benson and Powers express the benefits slightly differently, claiming that funding for multi- year periods lessens ‘the capacity for government to directly link funding to either approval or disapproval of programming.’ Figure 5: Length of funding cycles in years for public broadcasters Source: Toby Mendel, Public Service Broadcasting: A Comparative Survey (UNESCO, 2nd revised edition, 2011) 82 Toby Mendel, Public Service Broadcasting: A Comparative Legal Survey (UNESCO, 2nd revised edition, 2011) 72. 83 Recommendation No. R (96) 10 Guidelines on the guarantee of public service broadcasting (Council of Europe) 1996. 84 Rodney Benson and Matthew Powers, Public Media and Political Independence: Lessons for the Future of Journalism from Around the World (Freepress, 2011) 12.
Half-life 7.5 -14 hrs PD: block cyclooxygenase and inhibit prostaglandin production to produce effects Fever, rash and elevated LFT’s Hold if active infection Preg B, trimester specific Corticosteroids oral DOSE: < or = to 10mg of prednisone or equivalent QD. Should only be used for flares and bridging therapy PK: liver, CYP450:3A4 substrate Half-life varies on drug PD: possibly inhibits inflammatory cytokines Hypertension, hyperglycemia Increases risk for shingles Increases risk for infection Increase risk for osteoporosis Increase risk for cataracts Mood alteration Weight gain Adrenal insufficiency B/P, CMP, DXA B/P, weight gain, SOB, polyuria, polydipsia, edema, visual changes Urinalysis for glucose yearly Preg B Leflunomide DOSE 10-20mg per day PK: liver, GI tract, CYP450 Half life 15 -18 days PD: inhibits pyimidine synthesisvia dihydroorotate dehydrogenase inhibition, resulting in immunomodulatory and antiproliferative activity Myelosuppression, Increase risk for infection Increase risk for shingles Hold if active infection Screening for Hep B & C to start. Symptoms of myelosuppression CBC, Creatinine, liver enzymes every 8 to 12 weeks (q 2 months) Preg X Methotrexate Oral or SQ DOSE: titrated by symtpoms and labs. Usual start dose is 7.5mg to 10 Myelosuppression, hepatic toxicity and/or fibrosis, cirrhosis, pulmonary infiltrates/fibrosis Increase risk for infection Increase risk for shingles CBC, Hepatitis B and C serology, LFT;s albumin, bilirubin and creatinine. Chest Xray with in the last year TB test Symptoms of myelosuppression, SOB, N/V, oral ulcers, hair loss. CBC and platelet count LFT’s, Creatinine and albumin Q 8 weeks. Monitor for infection Preg X
Half life: 18-32 days PD: binds to CD20 surface antigens infusion rxn and/or mucocutaneous rxn. Hep B reactivation Caution if malignancy risk Hold if active infection Pregnancy status, and birth control measures during tx and 12 months after BIOLOGICS TNF alpha Inhibitors DRUG/PK/PD TOXICITIES / SE TO MONITOR BASELINE MONITORING ROS/EXAM LABORATORY / MONITORING Infliximab Enteracept Adalimumab Golimumab Certolizumab pergol DOSE: Varies by drug and route PK: CYP450:none PD: inhibits tumor necrosis factor alpha, reducing inflammation and altering immune response. S/S of immune suppression S/S of melanoma Worsening CHF Hold if active infection Hep B & C screen, TB screen, immunization status. S/S of infection or malignancy Increased risk for lymphoma and melanoma CHF Drug induced lupus CBC Preg Cat.B
Patient Full Name: Date of Birth: Address: Contact telephone no.: Site identifier: a <Insert procedure name> is going to be performed. What will happen during the procedure? < Provide a description of the procedure> What are the risks? < Insert an explanation of the possible risks here> Patient health status can have a significant effect on the risks to a patient undergoing a procedure. Please list the indicators that may influence the risk of this procedure: Allergy/asthma status Diabetes status Kidney, heart, thyroid disease Pregnancy and/or breastfeeding status Medications that the patient is currently taking, including herbal and supplements Implanted medical devices such as pacemakers, stents and cochlear implants Previous reactions to contrast After the procedure - things you need to know. How the patient may feel Instructions for ongoing care after the procedure Instructions for reporting adverse effects The above information has been explained to me and I consent to the procedure: Name (Please print) Witness (please print) Signed Signed Date Date
Appendix 10 – Electrical Installation Testing Record Sheet Project: Date of Test: Address: Tester: Licence No: Area: Supervisor: Continuity IR Polarity Fault Loop Impedance RCD Test Point/ Circuit Number Conductor Sizes (mm²) MCB (Rating & Type) Active (Rph) Earth (Re) Fail Pass/ Fail Correct Circuit Connections Pass/ Fail Polarity Measured Loop Value R Maximum Permitted Loop Value R Pass/ Fail RCD Fail RCD Trip Time (mSec) Main Earth
Date Journey Details : 1) From –To (location&post code) 2)Sngl/Rtn journey Mode of Transport (Bus, Train, Car, Bike etc) Mileage and/or Cost Reason for journey: Full location details Office Use only EXCESS ACCOMMODATION Dates (from-till) Accommodation details - (type/location etc) Cost Accommodation claimed (cheapest) = £ ………… Placement: Term-time: Overall Claim Total: £………………………… Student Signature: ……………………………………….
Please list the name(s) of the practice nurse(s) who work in your practice: Tick this box if you have no practice nurses Name of Practice Nurse(s) Gender (M/F) Languages spoken than English) Sessions or half days worked/ week Days of week worked (M,T,W,T,F,S) Willing and interested to participate (Y or N) Please list the name(s) of the Practice Manager(s) who work in your practice: Practice Manager(s) Name Gender (M/F) Authorised to give overall consent (Y or N) Please list the name(s) of the receptionist & administrative staff who work in your practice: Tick this box if you have no reception or administrative staff Receptionist or Administrative staff member’s Name Gender (M/F) Languages spoken Sessions or half days worked/week Days of week worked Willing and interested to participate (Y or N) 1. 2. 3. 4.
The drug substance manufacturing site(s) proposed for registration in Singapore as listed below is(are) the same as that approved by the specified reference agency. Manufacturing Activity Name and Address of the site(s) Manufacturing Manufacturing (final process step, e.g. purification/ crystallization or micronisation) [To indicate only one site in each row] [To duplicate row if necessary] The drug substance manufacturing process proposed for registration in Singapore is the same as that approved by the specified reference agency. The container closure system and retest period proposed for registration in Singapore as listed below are the same as that approved by the specified reference agency. Container Closure System Storage Conditions Re-test Period Shelf Life (if applicable) Drug Product The drug product manufacturing site(s) proposed for registration in Singapore as listed below is(are) the same as that approved by the specified reference agency. Manufacturing Activity Name and Address of the Site(s) Drug Product Intermediate Bulk Production Primary Packaging Sterilisation Secondary Packaging Batch Release [To indicate only one site in each row] [To duplicate row if necessary]
Halton Children’s Trust ‘You said, we did’ Workshop PART A – TOPIC ITEM: Transition into Adult Services Themes: SEND; Mental Health; Young Carers into Adult Carers Support What worked well? What didn’t work well? YOU SAID Possible solutions? YOU SAID Children’s Trust response WE DID Many partners had a good understanding of the aims of the Thrive model Communication strategy .Not all people were aware of Thrive The police use ‘Thrive’ for their risk management tool, need to ensure that the mental health service isn’t confused with this. Are schools and colleges involved in Thrive? Will school be able to identify the difference between mental health problems and autism? Agreed with the idea of having an online directory of mental health services Old website not easy to navigate and not user friendly. Need to make it more accessible, through Google/Bing leaflets/ clips Make sure the schools link workers and educational psychologists are also working closely with School nurses Online directory of services should use the ‘Hub of Hope’ Advised that would chase up launch date of new website and inform Children’s Trust A survey is underway on the name of the new service, and a communications campaign will launch it. Brand local service under this name. Develop a name for the children’s mental health service and branding attached. It won’t be under the banner of Thrive All schools have a mental health link worker Mental health is often a topic discussed in School nurse drop in sessions. School nurses will know the named link workers for each school and work closely with them when supporting children and young people. When working with school mental health staff will make it clear that it is not the role of the teachers to diagnose conditions. They are being asked to identify individuals who may need more emotional health support, and put in place early help, and refer appropriately. Health professionals will diagnose as is currently the case. The ‘Hub of hope’ is the preferred model and is currently being explored and populated. Informed Children’s Trust of the new website launch on 25/09/2017
Idea Store Canary Wharf, Churchill Place, London, E14 5RB Monday – Thursday 9am – 9pm, Friday 9am – 6pm, Saturday 9am – 5pm, Sunday 12pm – 6pm Cubitt Town Library, Strattondale Street, London, E14 3HG Monday – Wednesday 10am – 6pm, Thursday 10am-8pm, Friday 10am – 6pm, Saturday 9am – 5pm, Sunday closed. History & Archives Library, 277 Bancroft Road, E1 4DQ Monday closed, Tuesday 10am-5pm, Wednesday 9am-5pm, Thursday 9am-8pm, Friday closed, Saturday (first and third Saturday of the month) 9am-5pm, Sunday closed.
Community involvement and participation before adopting a SPD Method/Type of Consultation Aim/details Target Groups Date and Location Masterplan SPD media public notices and publication on LBTH website Raising awareness amongst the community of statutory consultation and events, plus inviting participation Local community East End Life/LBTH website December 22nd 2014 and January 19th 2015 (East End Life) December - April 2015 (website) and letters Raising awareness amongst the community and subscribers to the Council’s planning policy contact list of statutory consultation and events, plus inviting participation Local community, statutory consultees, other interested parties Letters and e-mails sent 2nd January 2015. E-mails were also sent on 16th January Public Drop-in Sessions To discuss the content of the Masterplan SPD and invite comment The general public Jack Dash House 22nd January 2015 Idea Store Canary Wharf 30th January 2015 Public Meeting/Presentation session Presentation of draft Masterplan to the general public with Question and Answers session The general public Alpha Grove Community Centre 5th February 2015 Landowner and developer forum To engage with and update key landowners and developers Key landowners and developers in the area. LBTH Town Hall 13th February 2015 Strategic Environmental Assessment Screening Determination notification email and scoping report consultation It was identified that the Masterplan SPD required an SEA, in accordance with the requirements of regulation 9(1) of the Environmental Assessment of Plans and Programmes Regulations 2004. The council was keen to understand whether consultees agreed with the proposed scope of the Strategic Environmental Assessment, or whether additional information/ assessment was required Statutory environmental bodies (Environment Agency, English Heritage, Natural England) and other interested stakeholders LBTH website 15th September – October 20th 2014 One-to-one meetings The Masterplan project team has offered bespoke one to meetings throughout the informal consultation period Interested individuals, groups and organisations LBTH Town Hall March-December 2014 Stage 3 - Adopting the Masterplan: October 2015 Final version of SPD with accompanying appendices Briefing the elected Mayor and Lead Member for Housing on the Masterplan SPD Council’s Mayor in Cabinet meeting 8th October 2015
Attachment 2 – Quality Improvement Register Improvement Action Item (include description of event/issue leading to the identification of improvement area) Source (eg. Patient, Referrer, etc) Action Undertaken Person Responsible for Agreed Action Completion Date The current Quality Improvement Register is kept in the general office. more pages as required.
Percentage of Home Choice Plus applications assessed and applicant notified of decision within 10 working days 90% 39% Not Achieved. Although target has not been achieved there has been a sustained improvement in performance supported by new structure, staff training and improved processes. Quarter 4 achieved 99.5%. Percentage of Disabled Facilities Grants (DFG) applications are processed within the average end to end time (referral to completion) of 244 calendar days 210 calendar days (average) 100% Achieved. Quarter 4 applications were processed within 153 days. The number and locations of Customer Access Terminals (CAT) installed per annum TBC following review n/a Not Achieved. The review was undertaken and the recommendation being that the network is retained. However, it was also agreed that an awareness campaign is required to increase usage. Percentage of residents who feel that they can influence decisions in local area (SDC Residents Survey) 35% 37% Achieved. A four percentage point increase in satisfaction compared to the 2014 result. Corporate Health Indicators Number of sick days per FTE 7.5 days 7.5 days Achieved. Number of Corporate Complaints (only the complaints deemed to be justified investigation into the complaint) No target set – reported for information only 40 complaints received of which 12 were ‘Justified’ Reported for information only.
Percentage of invoices paid within 10 days (excluding creditors who have their own bespoke payment terms) 99% 93.38% Not Achieved. Performance was down early in 2017/18, in the main relating to significant demand within the Housing Team. Performance has consistently improved during the year. Return on investments 10% higher than the LIBID rate 20% Achieved. Benchmark is 0.10% against actual net return of 0.12% which is 20% over target. Percentage of residents who say that they are satisfied with the way SDC runs things (SDC Residents Survey) 76% 77% Achieved. A one percentage point increase in satisfaction compared to the 2014 result. Percentage of residents who think SDC provides value for money (SDC Citizens’ Panel) 89% 89% Achieved. Overall CSI – Customer Satisfaction with Council services (SDC Customer Satisfaction Index) 75% n/a Reported Year 4 (2018/19). Survey undertaken every two years. Overall satisfaction of service received on contact with the Council (SDC Residents Survey) 72% 76% Achieved. A five percentage increase in satisfaction compared to the 2014 result.
accordance with IDP infrastructure trajectory Tables 2 and 3) Canal Quarter Localised Mitigation Package including bridge over canal (see IDP infrastructure trajectory Table 4) Public transport investments, pedestrian and links and highway safety measures Site specific mitigation for public transport investment, pedestrian and cycle links Public transport and other pedestrian/cycle infrastructure to mitigate development at GLH and LMA (in accordance with IDP infrastructure trajectory Tables 2 and 3) Education provision comprising Primary, Early Years, Secondary, Sixth Form or Special Educational Needs provision Education provision comprising Primary, Years, Secondary, Sixth Form or Special Educational Needs provision required to serve development at GLH and LMA Primary (general practice, optometry, dentistry and pharmacy), Acute and Community Health Care infrastructure Primary health care infrastructure to serve development at GLH and LMA Emergency Services facilities including CCTV provision Safer Neighbourhoods Premises and other directly related emergency services infrastructure to serve development at GLH and LMA Library and Community Services investment Library and Community Services Facility investment to serve development at GLH and LMA Off‐site Indoor Sport Investment/Provision Indoor Sport Provision to serve development at GLH and LMA Off‐site Outdoor Sport Investment/Provision Outdoor Sport Provision to serve development at GLH and LMA Allotments and community Orchards Investment/Provision Allotments and community orchards provision to serve development at GLH and LMA Natural and semi‐natural accessible green space Investment/Provision Natural and semi natural accessible green space provision to serve development at GLH and LMA Strategic and civic spaces Investment/Provision Civic spaces provision to serve development at GLH and LMA Mitigation for site specific green infrastructure and loss of biodiversity as a result of development impact On site open space including children’s play, local parks, gardens and amenity spaces
76.The use of the term “good’ in criterion f) is an inappropriate value judgment and unnecessary. RECOMMENDATION 6 the definition of live-work units in footnote 15 as follows: “ The dual use of a purpose built or converted building as a combination of dwelling and business space as defined by Class B1 of the Town and Country Planning (Use Classes) Order 1987. The ratio of uses in floor space terms must be relatively equal. ” Delete criterion d). In criterion f) delete “Good” and insert “The” in its Policy EC6 Raising the leisure and tourism profile of the town 77.This policy supports tourism development with none of the qualifications applied in Core Strategy policy CS.24 “Tourism and Leisure Development”. It is therefore contrary to basic conditions and should be deleted. 78.It is possible to retain a reference to the desire to promote tourism as part of the economic strategy in the Plan but this should be limited to a cross reference to the Core Strategy policy. This can be achieved in an amended form of policy EC7. RECOMMENDATION 7 Delete “Policy EC6”. Policy EC7 A better location for visitor and tourism information 79.The need to site such development within the town centre area, as defined on the policies map, should be more explicit. 80.The desire to promote tourism as referred to in the “deleted” policy EC 6 could be re-asserted in the Explanation section. RECOMMENDATION 8 In the policy, delete “new town centre”, add at the end of the sentence “within the town centre boundary highlighted on the policies map.”
The composition of proprietary materials (e.g. capsule shells, colouring blends, imprinting inks) should be submitted, if applicable. * * * * * 3.2.P.2 Pharmaceutical Development to ICH Q8 Part II – Annex for the documentary requirements for development and manufacturing processes that adopt the principles of enhanced approach (QbD) Refer to Guidance document, Section 15.3.2 or 18.3.2 for details. 3.2.P.2.1 Components of the Drug Product 3.2.P.2.1.1 Drug Substance 3.2.P.2.1.2 Excipients The choice of excipients listed in 3.2.P.1, their concentration and characteristics that can influence the drug product performance should be discussed and submitted. The use of antioxidant(s) and/or preservative(s), and their concentration(s) should be explained, fully justified and submitted, if applicable. 3.2.P.2.2 Drug Product 3.2.P.2.2.1 Formulation Development 3.2.P.2.2.2 Overages The use of overages should be explained, fully justified and submitted, if applicable. 3.2.P.2.2.3 Physicochemical and Biological Properties 3.2.P.2.3 Manufacturing Process Development 3.2.P.2.4 Container Closure System
were potential issues for professionals.with dependants in terms of timings of meetings; this would be exacerbated for those who work part-time. Ethnicity: Children/family/carers whose first language is not English may have particular interpreting / translation needs, also they may not have an understanding of the complexities of the social care system and procedures in NI, Through the screenong process it was identified that there may be issues identified in relation to children who are refugees, asylum seekers, or traveller children who may be less likely to have been picked up in the social care system.and are therefore more likely to slip through the net. Sexual orientation: It was identified that there may be needs in relation to same-sex parents. The appointment of the panel of CMR team chairs needs to take account of equality and human rights issues. The CMR notification Form does seek some information in relation to the Section 75 groups. There may be a need to review the form in terms of including the other groups.
YEAR THREE Aims (KSF indicator) The placement aims to provide opportunities for the student to Outcomes (KSF applications) By the end of all the placements the student will be able to demonstrate the ability to Examples of Evidence 1: Communication KSF core dimension, level 2 Interact with a range of clients, carers and professionals in an appropriate manner Disseminate information effectively Adapt communication (oral and written) to context and needs of clients, carers and others Seek and share information with a client/carer/other Video of session with client Written report on a client using appropriate style and content Verbal summary of key points following a team discussion 2: Personal and people development KSF core dimension, level 2 Personal Develop knowledge and skills, reflective practice and self monitoring skills People Provide information to others to enhance their knowledge and understanding, and to help them support the SLT intervention Personal Identify own strengths and weaknesses / areas to develop, set appropriate objectives, monitor effectiveness and progress implement some changes Develop some autonomy with decreasing reliance on the placement educator People Consider the type, extent and manner of information to be shared with others (e.g. clients, carers, other professionals) Personal Experiences and expectations form ABCD placement objective setting PDP form Tutor visit/video Weekly session plan (self evaluation), documenting and reviewing what and how behaviours have changed Self completion of placement report half way through placement placement educator’s and tutors’ comments on placement report forms In/dependence rating on placement report form People Adapt information for teacher and for a parent, outlining how and why style and/or content are different Clinical tutorial discussion / case report Provide placement educator with a journal article regarding a disorder / intervention 3: Health, safety and security KSF core dimension, level 2 Ensure adherence to Trust and Cardiff Met health and safety guidance Work in a way that minimises risks to own and others’ health, safety and security Attendance certificate of H and S training (and any further Trust training as required) Read Trust guidance on care of personal and Trust belongings Modifying equipment e.g. selecting larger items for child who ‘mouths’ objects Ensure equipment is sterile e.g. toy cup cleaned after used for symbolic play drinking 4: Service improvement
2014/2015 2015/2016 2016/2017 Planned Spend 2017/2018 Service Amount (£) Commissioner Service Amount (£) Commissioner Service Amount (£) Commissioner Service Amount (£) Commissioner CAMHS Tier 3 (5BP) 1,2,000 CCG CAMHS 1,200, plus uplift of 1.63% total £1219560 CCG CAMHS (tier 3) 1,200,00 plus uplift of1.1% net total £1232975 CCG THRIVE model 1,2000 plus uplift total £1234207 CCG CAMHS (tier 2 (Bridgewater £400k CCG CAMHS (tier 2 5BP +KOOTH investment PH) Circa £375k (9 months) CCG/LA CAMHS (tier 2 +KOOTH) Circa £500k CCG/LA THRIVE Circa £500k CCG/LA Eating disorder service age 14-16 ( within Tier 3 CAMHS £40k (approx.) CCG Eating disorder service age 14-16 ( within Tier 3 CAMHS £40k CCG Eating disorder service age 14-16 ( within Tier 3 PLUS new specialist service from Feb 17 Mid Mersey Commission) £19654 (qtr 4 Funding only) CCG( Mid Mersey commission) Specialist eating disorder £117926 ( recurrent) CCG (Mid Mersey commission) Young Addaction (substance misuse/ hidden Harm service) £190030 LA Addaction (substance misuse/ hidden Harm service) £190030 LA/CCG – CCG additional contribution of £15k ( non recurrent) Addaction (substance misuse/ hidden Harm service) £190030 LA Addaction (substance misuse/ hidden Harm service) £190030 LA Hear for You (Barnardos counselling service) LA 2014/15 2015/16 2016/17 Planned spend 18/19
Going Forward (Barnardos CIC service) £191240 LA Going Forward (Barnardos CIC service) £191240 LA Forward (Barnardos CIC service) £191240 LA Going Forward (Barnardos CIC service) £191240 ( under review for possible changed commission) LA School Health, Health Visiting £1017000 Public Health School Health, Health Visiting and Family Nurse Partnership 2,367,000 (NB only 6 mths for HV/FNP service following novation from NHSE. LA School Health, Health Visiting and Family Nurse Partnership £3,674,000 LA School Health, Health Visiting and Family Nurse Partnership £3,450,000 LA Child Development Centre (SD/ADHD pathway) CCG Chlid Centre GGG Child Development Centre Additional 90K CCG Child Development Centre Recurrent spend from previous year CCG Schools Link Pilot £100k including staff backfill Central funding bid Schools Link Pilot 50k (no backfill costs) CCG Schools Link Pilot 50k ( no back fill costs) CCG Schools Link Pilot Recurrent spend from previous year CCG YOT service 8k CCG YOT service investment following JSNA findings 58k CCG YOT service 50K CCG YOT service Recurrent spend from previous year CCG Perinatal MH Perinatal MH £20k protected midwifery time ( new spend) CCG
Attachment service Attachment service BIBS £40k ( new spend) CCG System wide investment via grants to 3rd sector investment 0 CCG System wide investment via grants to 3rd sector £117k spanned 2 financial years CCG System wide investment via grants to 3rd sector organisations £117k panned 2 financial years CCG System wide investment via grants to 3rd sector organisations following evaluation of pilots £65k CCG A&E Psychiatric liaison at WHHFT 0 CCG A&E Psychiatric liaison at WHHFT 30k CCG A&E Psychiatric liaison at WHHFT 30K CCG A&E Psychiatric liaison at WHHFT 30K CCG
Roles and Responsibilities Listed below are the details on the roles and responsibilities of the Project Manager and the Clinical Liaison and the co-sponsors. to the RASCI (Responsible, Accountable, Supportive, Consulted, and Informed) Chart, including the component RASCI charts developed for F&E/IT and Digital Imaging (DI) (referenced in Chapter 7), included as an appendix to the Health Facilities Capital Manual for the responsibilities and accountabilities between AHS, HEALTH and INFRA. AHS HEALTH Develop the AHS Strategic Direction, Service Delivery and the Long-Term Capital Plan and Annual Plan submissions to HEALTH; Define the project and objectives; Develop the project needs assessment and assist in the business case development, the functional program, Project Charter, and Project Management Plan; Jointly with INFRA and HEALTH, prepare and manage the Communication Plan; Review and approve, with INFRA, the business case, functional program, and Project Charter and BPE framework and any related changes; Approve, with INFRA, the Project Management Plan and key resources; Lead the development of the business case, functional program, Project Charter, Project Management Plan, Value Management Plan and Risk Management Plan and BPE framework; Accountable for scheduling. budgeting, cost controls, and project accounting of approved project; With guidance from client representative and Project Sponsor, HEALTH, jointly develop and support the Communications Plan; Chair Project Steering Committee; Assist in determining the site and lead the purchase of the site, if applicable; Acquire, develop and monitor project resources including the procurement, selection and contracting of the design Determine Health Capital Plan Priorities; Review and approve the needs assessment; Support business case and functional program development; Submit the business case to TBF for approval; Approve the functional program; Provide consultation on schematic and design development; Manage the sod turning ceremony in consultation with AHS and INFRA; Participate in the Project Steering Committee; and,
will seek assurance from member agencies on how the objective of promoting communication with children and young people has been met with particular reference to Section 75 groups of children and young people whose voices are easily ignored (including very young children, those with sensory and learning disabilities, those from black and minority ethnic backgrounds and young people who are lesbian, gay, bisexual or transgender). Link to Strategic Priority 3 ‘Working in Partnership to ensure children and young people are living in safety and with stability’ and cross-cutting Ensuring that children’s views and opinions are considered within the child protection and safeguarding system. Section 75 groups of children and young people whose voices are easily ignored are heard by member agencies. Self-Audit information from member agencies. Annually. What we did over the last year This information was collected as part of the Section 12 Audit.
This action is ongoing 75 monitoring Work with PHA, BSO and partner organisations to develop communication strategy for staff on rationale for collecting data. Robust data is in place to allow assessment of impacts and developing targeted actions. Communication strategy developed. Director of Operations with support from BSO Equality Unit What we did over the last year This action is ongoing.
SECTION B Your current address Provide your current address in Section B. Your DBS certificate will be sent to this address. It is your responsibility to ensure the address is correct. You must provide: The house name / number and street The town / city The county The postcode The country Enter the date you moved into your current address in B37 using the MMYYYY format only SECTION C Provide all other addresses you have resided at in the last five years in section C. For previous addresses, enter the date you moved into and out of each of the addresses using the MMYYYY format only. For each address, ensure you provide: The house name / number and street The town / city The county The postcode The country Date you moved in and date you moved out SECTION D Do not complete section D. SECTION E Criminal convictions, cautions, - Answer either NO or YES to Question 55. Sign & date the declaration (Staying within the box provided). The College reserves the right to withdraw a college place at any time if criminal convictions, pending sentencing or bail conditions are not disclosed to the College.
Tools without electrical plugs, (just bare wires) Damaged insulation i.e. worn electrical cables, exposed wiring, non earthed wiring, etc electrocution Equipment maintenance Training on proper use of electrical hand tools Effective supervision Equipment tag out if damaged Trained first aiders Effective Incident management Emergency response plans. Trained responders. Medics. Clinic. Activity - Operating Forklift – Rig Operation Risk Assessment Matrix (RAM) People/ Environment / Assets/Reputation (PEAR) Preventive Measures Mitigate Risk Assessment Matrix (RAM) People/ Environment / Assets/Reputation (PEAR) with new controls in place (Residual) PDO or other reference to etc HAZARDS (Potential to do harm) THREAT (scenario) Event Consequence Probability (how likely) (letter) Consequence (how bad) (number) Controls (Barriers) Recovery Probability (how likely) Consequence (how bad) Forklift in motion (driving too fast with load at top of mast) Incompetent inexperienced operator Loss of control of the forklift causing a tip over Fatality C 4P Assignment of licensed forklift operators Competence training for forklift operators Testing and verification by an accredited training provider Effective supervision and management Control of allocation of forklift keys Competent Rigger Banks man Effective load management Practiced emergency response Trained first aid responders Effective Incident management Emergency response plans. Qualified Medics. Communication set Thuraya Ambulance and Clinic. B 1 (P) Note: Incorporating lessons learned and findings from safety observations should be a part of TBT & JHA, it promotes awareness, thus improving safety performance and prevention of injuries. The above examples are for illustrative purposes only - purely examples to illustrate the principle Activity = Hazardous activity due to the “hazards associated with the activity” Threat is that that can release, unleash or cause the hazard to be realised examples: Threats are issues like Corrosion, over pressurisation, hot surfaces, alcohol, fatigue, sub standard practices, lack of attention or experience, poor visibility, speed etc Not all control barriers have been included in the above examples Determination of residual risk is dependent on contractor’s assessment
Severity RISK ASSESSMENT MATRIX Consequences Increasing Likelihood People Assets Environment Reputation A B C D E Never heard of in the Industry of in the Industry Has happened in the Company or more than once per year in the Industry Has happened at the location or more than once per year in the Company Has happened more than once per year at the Location 0 No injury or health effect No damage No effect No impact 1 Slight injury or health effect Slight damage Slight effect Slight impact 2 injury or health effect Minor damage Minor effect Minor impact 3 Major injury or health effect Moderate damage Moderate effect Moderate impact 4 Permanent or total disability or up to 3 fatalities damage Major effect Major impact 5 More than 3 fatalities Massive damage Massive effect Massive impact
Procedure Create draft ITSAC Solicitation Submit to customer for final review and approval. Prepare e-mail notification for respective vendors to receive solicitation. Date of Last Revision 12/2016 Procedure 2.30.10 ITSAC Vendor Notification Purpose To provide the notice of solicitation opportunities to eligible ITSAC vendors When to Use Any time a ITSAC Solicitation is issued Responsibility DIR Contract Specialist
NON-COLLUSION AFFIDAVIT Solicitation #: 18-15 Solicitation Name: SANITARY SEWER REHABILITATION FOR ZEKIAH & BRYANS ROAD Bidder/Offeror/Quoter: I do solemnly declare and affirm, under the penalties of perjury, the following: 1. That neither I, nor the best of my knowledge, information and belief, the Bidder/Offeror/Quoter, nor any officer, director, partner, member, associate or employee of the Bidder/Offeror/Quoter, nor any person in his behalf, has in any way agreed, connived or colluded with any one for and on behalf of the Bidder/Offeror/Quoter, to obtain information that would give the Bidder/Offeror/Quoter an unfair advantage over others, nor gain any favoritism in the award of this contract, nor in any way to produce a deceptive show of competition in the matter of bidding or award of this contract. 2. That neither I, nor the best of my knowledge, information and belief, the Bidder/Offeror/Quoter, nor any officer, director, partner, member, associate of the Bidder/Offeror/Quoter, nor any of its employees directly involved in obtaining contracts with the State of Maryland or any County or any subdivision of the State has been convicted of bribery, attempted bribery or conspiracy to bribe under the laws of any State or Federal Government of acts or omissions committed after July 1, 1977, except as noted below: All pursuant to Article 78A, Section 16D of the Annotated Code of Maryland. Signature Name and Title of Signer Company Date Subscribed to and sworn to before me, a Notary Public of the State of County or City of this year and date first written above. Notary Public My Commission Expire
Ensure the SPD and Equalities Analysis scoping report are reviewed annually The Council’s annual Monitoring Report will review the SPD and in turn this Equalities Analysis on an annual basis. Review on an annual basis in line with Council’s annual Monitoring Report TC Current SPD and Equalities Analysis scoping provides baseline position for review Section 7 – Sign Off and Publication Name: Adele Maher Position: Strategic Planning Manager Date signed off: 24/09/2015
2 Conduct a HSE workshop on HEMP for supervisory staff. HSE Manager May-2016 3 Presentation to Operations Manager on critical control points amendment. Quality Manager Feb-2016 4 Refer to Hazard Register for preparing Job HSE Plans. Supervisor Every PTW Road Transport/Journey Management No Action Action Schedule 1 Execute on each vehicle including vehicles for the compliance with SP-2000 Site Manager/ HSE Advisor Monthly 2 Make available updated light and heavy vehicles (May 2007) Journey Management MAP at journey managers office. HSE Manager/ Journey Mgr Mar-2016 3 Carry out drivers on job assessment and analyze the result. HSE Advisor May-2016, Nov-2016 4 Update RAS sticker once it gets expires. HSE Advisor Before expiry 5 Effectively monitor the use of shift commuting buses by logging passengers and random verification. Site Manager /Journey Mgr On each trip 6 Continue with campaign to promote awareness the use of private vehicle hazards and encourage to use company provided transport. Operation Mgr / HSE Advisor Mar-16, June-16, Sep-16, Dec-16 7 Ensure sub-contractor vehicle and drivers comply with Journey Management System Journey Manager, Site Manager Project Duration Behavior Based Programme No Action Action Party Schedule 1 Analyze behavior findings and report to contract holder. HSE Manager Monthly 2 out behavior observations. Site Manager/ Supervisor/ HSE Advisor Monthly Chemical Handling No Action Action Party Schedule 1 Ensure SHOC/MSDS are available at site for the chemical in use, update chemical list HSE Advisor/Camp Boss Monthly 2 Conduct Toolbox talks on risks of chemical exposure. HSE Advisor/Camp Boss Selected Week 3 Ensure all staff and sub-contractors staff issued the right PPE for handling of chemicals. Supervisors/Camp Boss Project Duration
The continuing suitability of Serious Services HSE objectives and consequent amendments to the HSE Plan and HSE Management System documenon if necessary Performance against targets Resources allocated to achieve HSE objectives. No Action Action Schedule 1 Review HSE Management System, QHSE Performance, and Accident/incident review. Contract Manager/ HSE Manager/ Quality Manager Jan-2016, April-2016, July-2016, October-2016 2 Review critical control point of food operation and prepare documentation for implementation. Quality Manager March-2016 3 HSE Plan compliance review of PDO contract. Contract Manager/ HSE Manager Monthly 4 Review HSE Plan and its implementation. HSE Manager Jan-2016
Firm’s Name and Address Date: FEIN: BID FORM The County Commissioners of Charles County, Maryland Charles County Government Building Post Office Box 2150 La Plata, Maryland 20646 This bid is submitted in accordance with your “Notice to Bidders” inviting bids to be received for the work outlined in the “Solicitation Document”, and the “Special Provisions” attached hereto for ITB No. 18-27, HISTORICAL WINDOW RESTORATION – BEL ALTON HIGH SCHOOL. Having carefully examined the solicitation documents, the undersigned herein agrees to furnish all services as outlined in the solicitation documents in the “Special Provisions” as stated, for the following prices: BASE BID ITEMS NO. DESCRIPTION OF ITEMS UNIT UNIT PRICE EST. QTY.* TOTAL PRICE A-1 Type A Sash Restoration & Repair Each $ 5 $ A-2 Type B Sash Restoration & Repair Each $ 16 $ A-3 Type C Sash Restoration & Repair Each $ 15 $ A-4 Type D Sash Restoration & Repair Each $ 10 $ A-5 Transom Restoration & Repair Each $ 3 $ A-6 Broken Pane Replacement Each $ 7 $ TOTAL BASE BID PRICE $ ALLOWANCE NO. DESCRIPTION OF ITEMS UNIT TOTAL PRICE B-1 Miscellaneous Wood Repairs Lump Sum $10,000.00 TOTAL ALLOWANCE PRICE $10,000.00